Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-24
2006-10-24
Richter, Johann (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S039000
Reexamination Certificate
active
07125884
ABSTRACT:
The present invention provides compound having the structure: and pharmaceutically acceptable salts or derivatives thereof, as well as compositions including such compounds. The invention also provides methods of (1) preventing pain, (2) treating pain, (3) inducing sedation, (4) treating opiate addiction, (5) treating opiate withdrawal (abstinence syndrome) and/or (6) treating cough in a patient in need thereof by administering a compound or composition of the invention.
REFERENCES:
patent: 3285914 (1966-11-01), Gordon et al.
patent: 5968547 (1999-10-01), Reder et al.
patent: WO 99/38869 (1999-08-01), None
J. Marton et al. “Herstellung von 6,14-Ethenomorphinan-Derivaten” Monatshefte fur Chemie 125 (11), 1229-1239 (1994).
Gale Donna-Donigi
Reidenberg Bruce E.
Srinivasan Vinayak J.
Darby & Darby
Euro-Celtique S.A.
Nwaonicha Chukwuma
Richter Johann
LandOfFree
N-but-3-enyl norbuprenorphine and its use as analgesic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-but-3-enyl norbuprenorphine and its use as analgesic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-but-3-enyl norbuprenorphine and its use as analgesic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3718765